title: Paul Brousse Liver Transplantation: the first 1,500 cases.
abstract: During the past 16 years, more than 1,500 liver transplants were performed at Paul Brousse Hospital. The overall patient survival rates were 83% at one year and 65% at 10 years. Our group has pioneered a variety of new approaches to liver transplantation, including: 1. Anti-HBs (HBIG) prophylaxis for the prevention of HBV recurrence. To date more than 270 patients have received long-term treatment and the overall 10-year recurrence rate was 27%. 2. Transplantation for hepatocellular carcinoma of the cirrhotic liver in patients with uni- or binodular HCC (< 3 cm). Survival for transplanted patients was 83% compared with 18% if the liver was resected. 3. Transplantation for familial amyloidotic polyneuropathy (FAP). More than 60 patients had 5- and 10-year survival rates of 85% and 83%, respectively. Ten livers obtained after hepatectomy from these FAP patients were transplanted as "domino" living donor livers to patients with unresectable liver cancers with satisfactory short-term results. 4. Reduced-size liver grafts have been used successfully to reduce pretransplant mortality and posttransplant morbidity and mortality by shortening the wait for our pediatric patients. 5. Split-liver transplantation has increased the number of transplantable livers by 28%. 6. Split-liver transplantation for 2 adults. Using optimal livers we have transplanted 34 adults with grafts prepared by ex-vivo or in-situ splitting with good survival rates. 7. Adult-to-adult living-related donor liver transplantation. In 2000, 7 adult-to-adult living donor transplants were performed with no complications from the donor surgeries. One recipient was retransplanted for arterial thrombosis, but all 7 recipients are alive at home. The Paul Brousse Hospital is committed to exploring new technologies to improve the outcome of and expand the indications for liver transplantation. We have taken a surgical approach to the organ shortage, finding new ways to serve the most patients with the limited number of livers available.
authors.affiliation: Centre Hépatobiliaire, UPRES 1596, Assistance Publique-Hôpitaux de Paris, Université Paris Sud, Hôpital Paul Brousse, Villejuif, France.
authors.forename: D
authors.initials: D
authors.lastname: Azoulay
authors.forename: D
authors.initials: D
authors.lastname: Samuel
authors.forename: R
authors.initials: R
authors.lastname: Adam
authors.forename: E
authors.initials: E
authors.lastname: Savier
authors.forename: V
authors.initials: V
authors.lastname: Karam
authors.forename: V
authors.initials: V
authors.lastname: Delvard
authors.forename: F
authors.initials: F
authors.lastname: Saliba
authors.forename: P
authors.initials: P
authors.lastname: Ichai
authors.forename: B
authors.initials: B
authors.lastname: Roche
authors.forename: C
authors.initials: C
authors.lastname: Feray
authors.forename: J C
authors.initials: JC
authors.lastname: Vallee
authors.forename: A
authors.initials: A
authors.lastname: Smail
authors.forename: D
authors.initials: D
authors.lastname: Castaing
authors.forename: H
authors.initials: H
authors.lastname: Bismuth
mesh_terms: D000328:Adult; D017772:Amyloid Neuropathies / Q000601:surgery; D006528:Carcinoma, Hepatocellular / Q000601:surgery; D005602:France / Q000453:epidemiology; D006505:Hepatitis / Q000601:surgery; D006779:Hospitals, Public; D006801:Humans; D008103:Liver Cirrhosis / Q000601:surgery; D008113:Liver Neoplasms / Q000601:surgery; D016031:Liver Transplantation / Q000379:methods / Q000401:mortality / Q000706:statistics & numerical data; D019520:Living Donors; D008659:Metabolic Diseases / Q000601:surgery; D015996:Survival Rate